D-K6L9
D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance .
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 426264-61-1
- Formel: C90H174N22O15
- Molecular Weight:1804.48
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 426264-61-1
-
Molecular Weight 1804.48
-
Formel C90H174N22O15
-
Sequence
Leu-Lys-{d-Leu}-Leu-Lys-{d-Lys}-Leu-{d-Leu}-{d-Lys}-Lys-Leu-Leu-{d-Lys}-Leu-Leu-NH2
-
Sequence Shortening
LK-{d-Leu}-LK-{d-Lys}-L-{d-Leu}-{d-Lys}-KLL-{d-Lys}-LL-NH2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)